Drug Approvals
🇺🇸 FDA Page 19FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 217–228 of 665 articles
altRx GLP-1 Review 2026: FDA Updates on Semaglutide
Replimune's Third FDA Approval Attempt and Pfizer's China Deal
Wockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma
Friday Five: Key Regulatory Updates in Pharma
Pennsylvania Compounding Pharmacy Receives FDA Warning Letter
China Approves HERNEXEOS for Lung Cancer Treatment
Eli Lilly's $3.8B Investment in Infectious Disease Portfolio
FDA's New Guidance on AI: Regulatory Restraint Explained
FDA Device Guidance Agenda: Key Regulatory Updates for 2026
STAT+: The Woman Behind the World’s Biggest Longevity Competition
Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
Philips Partners with Disney to Alleviate MRI Anxiety in Children